PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
APOA1 958 Target Disease Leukemias 14,152 1 0.00 -1.00 0.00 0.55
APOA1 958 Target Drug Abacavir 1,496 1 0.00 -1.00 0.00 0.61
APOA1 958 Target Target ACY1 51 1 0.00 -0.99 0.02 0.68
APOA1 958 Target Target Alpha-1 AntiChymotrypsin 1,460 1 0.00 -1.00 0.00 0.61
APOA1 958 Target Target APOE 12,771 118 0.03 -0.93 0.12 0.71
APOA1 958 Target Target Antithrombin 13,773 5 0.00 -1.00 0.01 0.59
APOA1 958 Target Disease Andropause 317 1 0.00 -1.00 0.00 0.65
APOA1 958 Target Disease Headache 50,687 1 0.00 -1.00 0.00 0.52
APOA1 958 Target Target Platelet Activating Factor 9,915 1 0.00 -1.00 0.00 0.56
APOA1 958 Target Disease Pain 409,851 4 0.00 -1.00 0.00 0.50
APOA1 958 Target Disease Psoriasis 26,882 4 0.00 -1.00 0.00 0.57
APOA1 958 Target Disease Diabetic Retinopathy 14,494 7 0.00 -1.00 0.01 0.60
APOA1 958 Target Target APOC1 126 9 0.03 -0.96 0.07 0.74
APOA1 958 Target Disease Sepsis 64,798 4 0.00 -1.00 0.00 0.54
APOA1 958 Target Target D-Dimer 6,185 3 0.00 -1.00 0.00 0.60
APOA1 958 Target Disease Autism 20,962 2 0.00 -1.00 0.00 0.56
APOA1 958 Target Target Renin 43,456 1 0.00 -1.00 0.00 0.52
APOA1 958 Target Disease Dementia 66,782 6 0.00 -1.00 0.01 0.55
APOA1 958 Target Target EGF 27,487 3 0.00 -1.00 0.00 0.56
APOA1 958 Target Target APOA2 118 25 0.07 -0.88 0.21 0.79
APOA1 958 Target Target Ricin 3,034 1 0.00 -1.00 0.00 0.59
APO-2L 90 Target Disease Infertility 35,448 1 0.00 -0.99 0.01 0.57
APO-2L 90 Target Disease Inflammation 252,734 3 0.00 -0.98 0.03 0.55
APO-2L 90 Target Disease Glioblastoma 17,933 1 0.00 -0.99 0.01 0.59
APO-2L 90 Target Drug Doxorubicin 28,033 3 0.00 -0.98 0.03 0.60
AP2M1 7 Target Disease Infection 766,637 1 0.00 -0.93 0.14 0.55
AP2M1 7 Target Disease Hepatitis 163,842 1 0.00 -0.93 0.14 0.58
ANXA7 35 Target Disease Glioblastoma 17,933 5 0.01 -0.93 0.14 0.64
ANXA7 35 Target Disease Anemia 81,663 1 0.00 -0.99 0.03 0.57
ANXA7 35 Target Disease Brain Tumors 16,749 3 0.00 -0.96 0.09 0.63
ANXA7 35 Target Disease Breast Cancer 173,695 2 0.00 -0.97 0.06 0.57
ANXA7 35 Target Disease Leukemia 162,805 1 0.00 -0.99 0.03 0.55
ANXA7 35 Target Target EGF 27,487 1 0.00 -0.99 0.03 0.59
ANXA7 35 Target Disease Dyslipidemia 15,225 1 0.00 -0.99 0.03 0.61
ANXA7 35 Target Target Collagen 138,882 1 0.00 -0.99 0.03 0.56
ANXA7 35 Target Target EPHB2 385 1 0.01 -0.98 0.03 0.71
ANXA7 35 Target Disease Epilepsy 71,172 1 0.00 -0.99 0.03 0.57
ANXA7 35 Target Target APOE 12,771 1 0.00 -0.99 0.03 0.61
ANXA7 35 Target Target Adenosine Deaminase 6,613 1 0.00 -0.99 0.03 0.63
ANXA7 35 Target Disease Diabetic Nephropathy 12,496 1 0.00 -0.99 0.03 0.61
ANXA7 35 Target Target Epidermal Growth Factor Receptor 24,772 1 0.00 -0.99 0.03 0.60
ANXA7 35 Target Target DAPK1 205 1 0.01 -0.98 0.03 0.74
ANXA7 35 Target Disease Shock 134,031 2 0.00 -0.97 0.06 0.57
ANXA7 35 Target Disease Schizophrenia 77,034 1 0.00 -0.99 0.03 0.57
ANXA7 35 Target Disease Prostate Cancer 71,064 7 0.00 -0.89 0.20 0.62
ANXA7 35 Target Target Calmodulin 25,240 1 0.00 -0.99 0.03 0.59
ANXA7 35 Target Disease Cancer 1,053,491 15 0.00 -0.76 0.43 0.57
ANXA7 35 Target Target ASK1 762 1 0.01 -0.98 0.03 0.69
ANXA7 35 Target Disease Carcinoma 433,099 3 0.00 -0.96 0.09 0.56
ANXA7 35 Target Disease Diabetes 332,602 1 0.00 -0.99 0.03 0.54